Please login to the form below

Not currently logged in
Email:
Password:

Former Quintiles president Jeff Thomis to chair Idis

Will oversee company’s activities to develop managed access programmes for medicines

Idis Jeff ThomisIdis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access programmes for medicines.

The appointment marks a change of direction for Thomis, who has spent a large part of his career in the management of clinical trials.

This includes 11 years at clinical research organisation (CRO) Quintiles, which he joined in 1998 as president clinical development Europe before being appointed as president of global clinical development services in 2006.

In his new role, Thomis will work with the board of Idis and its leadership team to develop programmes for pharma and biotech companies to provide unapproved medicines to patients with unmet medical needs.

“As specialists in the field, Idis is strongly placed to deliver highly effective solutions to our customers who include pharmaceutical and biotech companies, healthcare professionals and patients,” said Thomis.

Prior to his time at Quintiles, Thomis was director of infectious diseases at Bristol-Myers Squibb.

6th September 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...